$Bank of CN HK SDR 1to1 (HBND.SG)$  no dividends if we buy from this in sg versus the hk listed one?

So many investment opportunities are worth noting! Click to view the 2025 investment outlook>>

$Inovio Pharmaceuticals (INO.US)$Inovio Smallpox Vaccine Protects Against Monkeypox (2010)
https://www.drugdiscoverytrends.com/inovio-smallpox-vaccine-protects-against-monkeypox/

$Arcturus Therapeutics (ARCT.US)$
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
https://finance.yahoo.com/news/arcturus-announces-self-amplifying-covid-113000171.html

$Johnson & Johnson (JNJ.US)$
Dengue compound backed by J&J shows potency against the virus and all known variants in mice
https://www.fiercebiotech.com/research/dengue-pill-backed-by-j-j-shows-potency-against-virus-and-all-known-variants-mice

$Arcturus Therapeutics (ARCT.US)$Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern
https://finance.yahoo.com/news/arcturus-announces-approval-clinical-trial-130000038.html

$Vir Biotechnology (VIR.US)$ 
Some preliminary positive results for sotrovimab
"The primary efficacy analysis of all 1,057 patients in the COMET-ICE trial demonstrated a 79% reduction (adjusted relative risk reduction) (p<0.001) in hospitalization for more than 24 hours or death due to any cause, by Day 29 compared to placebo, meeting the primary endpoint of the trial"
https://www.globenewswire.com/news-release/2021/06/21/2250117/0/en/GSK-and-Vir-Biotechnology-Announce-Continuing-Progress-of-the-COMET-Clinical-Development-Program-for-Sotrovimab.html
https://www.reuters.com/article/health-coronavirus-gsk-usa/study-confirms-gsk-vir-antibody-drug-reduces-hospitalization-death-in-covid-19-patients-idUSL3N2O32Q9...

$Arcturus Therapeutics (ARCT.US)$ 
02 June 2021
Primordial Genetics Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase for Human and Animal Therapeutics
https://www.prnewswire.com/news-releases/primordial-genetics-grants-arcturus-therapeutics-exclusive-license-of-an-rna-polymerase-for-human-and-animal-therapeutics-301303621.html